WindRose Health Investors has announced a strategic investment in Stellus Rx.
Stellus Rx, founded in 2022 and based in Plano, Texas, provides pharmacist-led patient support and dispensing solutions.
WindRose, founded in 2000 and based in New York, pursues equity investments in healthcare companies. The firm invests in a broad range of industry segments, including outsourced services to payors and health systems, technology-enabled services, healthcare providers and value-added distribution.
Terms of the investment were not disclosed